Soleno Therapeutics
SLNO • NASDAQ
Soleno Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Anish Bhatnagar, with a market cap of $2.1B.
CEOAnish Bhatnagar
Next Earnings
Upcoming earnings announcement for Soleno Therapeutics
Date
Wednesday, May 6, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.76
Revenue Estimate
$95.6M
Earnings History
Past 12 earnings reports for Soleno Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 25, 2026 | Q4 2025 | $0.80Est: $0.68 | +17.6% | $91.7MEst: $89.3M | +2.7% |  10-K |
| Nov 4, 2025 | Q3 2025 | $0.47Est: $0.06 | +683.3% | $66.0MEst: $46.6M | +41.5% | 10-Q |
| Aug 6, 2025 | Q2 2025 | -$0.09Est: -$0.53 | +83.0% | -Est: $27.9M | -100.0% | 10-Q |
| May 7, 2025 | Q1 2025 | -$0.95 | — | - | — | 10-Q |
| Feb 27, 2025 | Q4 2024 | -$1.27Est: -$0.64 | -98.4% | - | — | 10-K |
| Nov 6, 2024 | Q3 2024 | -$1.83Est: -$0.63 | -190.5% | - | — | 10-Q |
| Aug 7, 2024 | Q2 2024 | -$0.57Est: -$0.63 | +9.5% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.59Est: -$0.37 | -59.5% | - | — | 10-Q |
| Mar 6, 2024 | Q4 2023 | -$0.33Est: -$0.27 | -22.2% | - | — | 10-K |
| Nov 7, 2023 | Q3 2023 | -$0.95Est: -$0.58 | -63.8% | - | — | — |
| Aug 8, 2023 | Q2 2023 | -$0.81Est: -$0.83 | +2.4% | - | — | 10-Q |
| May 9, 2023 | Q1 2023 | -$0.88Est: -$0.72 | -22.2% | - | — | — |